Table 5.
Pre-intervention (T1) |
Post-intervention (T2) |
1-month follow-up (T3) |
3-month follow-up (T4) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Measure | n | M | SD | Minimum | Maximum | n | Diff. | d | n | Diff. | d | n | Diff. | d |
Peritraumatic Distress Inventory (PDI) | 9 | 17.2 | 9.8 | 7 | 33 | 8 | −1.8 | −0.24 | ||||||
Patient Health Questionnaire 9 (PHQ-9) | 7 | 8.7 | 4.3 | 4 | 16 | 7 | −0.1 | −0.03 | 4 | −2.3 | −0.65 | 6 | −1.2 | −0.23 |
Generalized Anxiety Disorder 7 (GAD-7) | 7 | 13.4 | 4.8 | 5 | 19 | 7 | −1.7 | −0.41 | 4 | −1.5 | −0.24 | 5 | −1.4 | −0.29 |
HADS Depression | 3 | 13.3 | 3.8 | 9 | 16 | 2 | −1.0 | 0.00 | ||||||
HADS Anxiety | 3 | 15.7 | 3.5 | 12 | 19 | 2 | −3.5 | −0.90 | ||||||
Prolonged Grief 12/13 (PG-12/PG-13)a | 10 | 35.7 | 8.1 | 21 | 48 | 9 | −0.2 | −0.03 | 6 | −3.0 | −0.45 | 7 | −6.7 | −0.94 |
Brief Experiential Avoidance Questionnaire (BEAQ) | 10 | 47.4 | 12.7 | 33 | 70 | 9 | −4.3 | −0.23 | 6 | −3.0 | −0.21 | 7 | −5.0 | −0.30 |
Distress Tolerance Scale (DTS) | 9 | 11.7 | 5.5 | 6 | 20 | 8 | 0.0 | 0.00 | 6 | −1.2 | −0.23 | 7 | 0.7 | 0.14 |
Family Decision-Making Self Efficacy Scale (FDMSE) | 9 | 70.7 | 9.1 | 51 | 78 | 8 | −1.4 | −0.15 | ||||||
Impact of Events Scale-Revised (IES-R)b | 5 | 30.0 | 12.9 | 14 | 44 | 4 | −6.0 | −0.25 | 4 | −2.00 | 0.15 |
All participants were administered PG-12 at baseline and were administered PG-12 or PG-13 based on patient vital status at following timepoints.
First administered post-intervention (T2).